Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Du, Jin Xing ^a   Sun, Ming Yu ^a,b   Du, Guang Li ^a   Li, Feng Hua ^a   Liu, Cheng ^a   Mu, Yong Ping ^a   Chen, Gao Feng ^a   Long, Ai Hua ^a   Bian, Yan Qin ^a   Liu, Jia ^b   Liu, Cheng Hai ^a,b   Hu, Yi Yang ^a,b   Xu, Lie Ming ^a,b   Liu, Ping ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b E institute of Shanghai Municipal Education Commission   (China)

Author keywords

Cholestatic liver fibrosis; Extracellular signal regulated kinase; Ingredients of huangqi decoction; Smad signaling pathway; Transforming growth factor beta 1

Indexed keywords

HERBACEOUS AGENT; HUANGQI EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIARY TRACT FIBROSIS; BLOOD SAMPLING; CHOLESTASIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE COURSE; HISTOPATHOLOGY; LIVER; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; MALE; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84865120454     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-33     Document Type: Article

References (34)

1. Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol 2003, 200:504-515. 10.1002/path.1397, 12845618.
2. Clements WD, Erwin P, McCaigue MD, et al. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 1998, 42:293-299. 10.1136/gut.42.2.293, 1726981, 9536958.
3. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003, 125:178-191. 10.1016/S0016-5085(03)00666-8, 12851882.
4. Du JX, Qiu BF, Liu P, et al. Huangqi decoction inhibits cholangiocyte proliferation and transdifferentiation in cholestatic liver fibrosis induced by BDL in rats. Zhonghua Gan Zang Bing Za Zhi 2010, 18:13-18.
5. Erwin P, Bottinger MB. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002, 13:2600-2610. 10.1097/01.ASN.0000033611.79556.AE, 12239251.
6. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005, 21:659-693. 10.1146/annurev.cellbio.21.022404.142018, 16212511.
7. Franck V, Alain M. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007, 13:3056-3062.
8. Inagaki Y, Mamura M, Kanamaru Y, et al. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol 2001, 187:117-123. 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S, 11241356.
9. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem 1981, 112:70-75. 10.1016/0003-2697(81)90261-X, 7258630.
10. Xia JL, Dai C, Michalopoulos GK, et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 2006, 168:1500-1512. 10.2353/ajpath.2006.050747, 1606599, 16651617.
11. Khimji AK, Shao R, Rockey DC. Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation. Am J Pathol 2008, 173:716-727. 10.2353/ajpath.2008.071121, 2527071, 18753413.
12. Liu P, Fang BW, Liu C, et al. The role of transforming growth factor β1 and its receptor in immunological induced liver fibrogenesis in rats and effect of cordyceps polysaccharide on them. Zhonghua Gan Zang Bing Za Zhi 1998, 6:232-234.
13. Lutz M, Knaus P. Integration of the TGF-beta pathway into the cellular signalling network. Cell Signal 2002, 14:977-988. 10.1016/S0898-6568(02)00058-X, 12359303.
14. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998, 67:753-791. 10.1146/annurev.biochem.67.1.753, 9759503.
15. Mehra A, Wrana JL. TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol 2002, 80:605-622. 10.1139/o02-161, 12440701.
16. Ming DJ, Shu MZ, Hui X, et al. An experimental study of extracellular signal-regulated kinase and its interventional treatments in hepatic fibrosis. Hepatobiliary Pancreat Dis Int 2008, 7:51-57.
17. Qiu BF, Du JX, Shen DZ, et al. Mechanism of hepatocytes transdifferentiation to bile duct epithelial cells and intervention of huangqi decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010, 30:513-518.
18. Schnabl B, Kweon YO, Frederick JP, et al. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001, 34:89-100.
19. Seyhan H, Hamzavi J, Wiercinska E, et al. Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signalng. J Cell Mol Med 2006, 10:922-932. 10.1111/j.1582-4934.2006.tb00535.x, 17125595.
20. Shi LS, Zuo JG, Quan RZ, et al. Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol 2005, 11:2269-2276.
21. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700. 10.1016/S0092-8674(03)00432-X, 12809600.
22. Sime PJ, O' Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001, 99:308-319. 10.1006/clim.2001.5008, 11358425.
23. Stedman C, Robertson G, Coulter S, et al. Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J Biol Chem 2004, 279:11336-11343. 10.1074/jbc.M310258200, 14681232.
24. Tahashi Y, Matsuzaki K, Date M, et al. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002, 35:49-61. 10.1053/jhep.2002.30083, 11786959.
25. Ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004, 29:265-273. 10.1016/j.tibs.2004.03.008, 15130563.
26. Uemura M, Swenson ES, Gaca MD, et al. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Bilology Cell 2005, 16:4214-4224.
27. Wahl SM. Transforming growth factor-beta: innately bipolar. Curr Opin Immunol 2007, 19:55-62. 10.1016/j.coi.2006.11.008, 17137775.
28. Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem 2001, 276:14466-14473.
29. Chen WY, Chen CJ, Liao JW, et al. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci 2009, 84:606-614. 10.1016/j.lfs.2009.02.003, 19302800.
30. Wrana JL. Regulation of Smad activity. Cell 2000, 100:189-192. 10.1016/S0092-8674(00)81556-1, 10660041.
31. Yoshiji H, Kuriyama S, Yoshii J, et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001, 34:745-750. 10.1053/jhep.2001.28231, 11584371.
32. Nishikawa Y, Doi Y, Watanabe H, et al. Transdifferentiation of mature rat hepatocytes into bile duct-like cells in Vitro. Am J Pathol 2005, 166:1077-1088. 10.1016/S0002-9440(10)62328-0, 1602375, 15793288.
33. Zhao J, Shi W, Wang YL, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:585-593.
34. Zuo C, Xie C, Deng Y, et al. Effect of Astragalus mongholicus on expression of transforming growth factor-beta1 in SD rats with unilateral ureteral occlusion. Zhongguo Zhong Yao Za Zhi 2009, 34:193-198.